Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of EUR 97.40 billion. The enterprise value is 114.67 billion.
Market Cap | 97.40B |
Enterprise Value | 114.67B |
Important Dates
The last earnings date was Wednesday, May 21, 2025.
Earnings Date | May 21, 2025 |
Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
Current Share Class | 1.28B |
Shares Outstanding | n/a |
Shares Change (YoY) | -3.03% |
Shares Change (QoQ) | +0.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 23.74 and the forward PE ratio is 15.64.
PE Ratio | 23.74 |
Forward PE | 15.64 |
PS Ratio | 3.30 |
PB Ratio | 2.29 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.74, with an EV/FCF ratio of 25.13.
EV / Earnings | 27.95 |
EV / Sales | 3.92 |
EV / EBITDA | 13.74 |
EV / EBIT | 19.60 |
EV / FCF | 25.13 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.59.
Current Ratio | 1.85 |
Quick Ratio | 1.20 |
Debt / Equity | 0.59 |
Debt / EBITDA | 2.98 |
Debt / FCF | 5.50 |
Interest Coverage | 9.19 |
Financial Efficiency
Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.46%.
Return on Equity (ROE) | 9.51% |
Return on Assets (ROA) | 4.61% |
Return on Invested Capital (ROIC) | 5.46% |
Return on Capital Employed (ROCE) | 8.50% |
Revenue Per Employee | 310,659 |
Profits Per Employee | 43,185 |
Employee Count | 95,000 |
Asset Turnover | 0.37 |
Inventory Turnover | 2.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.55% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -3.55% |
50-Day Moving Average | 75.65 |
200-Day Moving Average | 80.63 |
Relative Strength Index (RSI) | 59.96 |
Average Volume (20 Days) | 30 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, Medtronic had revenue of EUR 29.51 billion and earned 4.10 billion in profits. Earnings per share was 3.18.
Revenue | 29.51B |
Gross Profit | 19.33B |
Operating Income | 5.90B |
Pretax Income | 4.95B |
Net Income | 4.10B |
EBITDA | 8.41B |
EBIT | 5.90B |
Earnings Per Share (EPS) | 3.18 |
Balance Sheet
The company has 7.89 billion in cash and 25.09 billion in debt, giving a net cash position of -17.20 billion.
Cash & Cash Equivalents | 7.89B |
Total Debt | 25.09B |
Net Cash | -17.20B |
Net Cash Per Share | n/a |
Equity (Book Value) | 42.47B |
Book Value Per Share | 32.97 |
Working Capital | 9.62B |
Cash Flow
In the last 12 months, operating cash flow was 6.20 billion and capital expenditures -1.64 billion, giving a free cash flow of 4.56 billion.
Operating Cash Flow | 6.20B |
Capital Expenditures | -1.64B |
Free Cash Flow | 4.56B |
FCF Per Share | n/a |
Margins
Gross margin is 65.51%, with operating and profit margins of 19.97% and 13.90%.
Gross Margin | 65.51% |
Operating Margin | 19.97% |
Pretax Margin | 16.78% |
Profit Margin | 13.90% |
EBITDA Margin | 28.51% |
EBIT Margin | 19.97% |
FCF Margin | 15.46% |
Dividends & Yields
This stock pays an annual dividend of 2.60, which amounts to a dividend yield of 3.59%.
Dividend Per Share | 2.60 |
Dividend Yield | 3.59% |
Dividend Growth (YoY) | 2.46% |
Years of Dividend Growth | 1 |
Payout Ratio | 76.98% |
Buyback Yield | 3.03% |
Shareholder Yield | 6.62% |
Earnings Yield | 4.21% |
FCF Yield | 4.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medtronic has an Altman Z-Score of 2.76. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.76 |
Piotroski F-Score | n/a |